Heart Attack Diagnostics Market Growth Drivers and Challenges:
Growth Drivers
- Rise in Geriatric Population Worldwide - Globally, there were 747,238,580 people over 60 years old at the end of 2021 according to a recent World Bank report. Future projections indicate an increase in the number. Cardiovascular disease is more prevalent among the elderly and the aging population. Adults with cardiovascular disease are at an increased risk of CVD owing to their age, which is increased by contributing factors such as fragility, overweight, and diabetes. Moreover, aging populations are more likely to suffer from heart attacks because they are more vulnerable to heart diseases.
- Higher Level of Cholesterol Among People- As per the data by the Centers for Disease Control and Prevention, the total cholesterol level of nearly 94 million U.S. adults aged 20 or older exceeds 200 mg/dL. A total of 28 million Americans has a cholesterol level above 240 milligrams per deciliter.
- Increasing Consumption of Alcohol - The consumption of alcohol is directly related to a higher risk of stroke and heart failure. According to a survey of adults ages 18 and older, 84% reported drinking alcohol at some point in their lives across the globe.
- High Rate of Tobacco Smoking- For instance, the number of adults smoking cigarettes in the United States is estimated at 30.8 million. There are more than 16 million Americans who suffer from smoking-related diseases.
- Prevalence of Unhealthy Lifestyles Among People - It was observed that, there are approximately 677,000 deaths each year in the United States as a result of unhealthy lifestyles, such as cardiovascular disease, cancer, and diabetes, which are linked to nutrition and obesity.
Challenges
- Higher Price Associated with Diagnostic Products – Even if heart attack cases are increasing at an alarming rate, heart attack diagnostic procedure cost a fortune owing to high price of diagnostic products. As a result, the population with middle income is expected to slower the adoption rate of heart diagnostic in the forecast period.
- Shortage of Skilled Medical Professionals
- Inadequate Medicare Reimbursement Policies
Heart Attack Diagnostics Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Period |
2026-2035 |
|
CAGR |
7.5% |
|
Base Year Market Size (2025) |
USD 13.14 billion |
|
Forecast Year Market Size (2035) |
USD 27.08 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of heart attack diagnostics is evaluated at USD 14.03 billion.
The global heart attack diagnostics market size was worth over USD 13.14 billion in 2025 and is poised to grow at a CAGR of around 7.5%, reaching USD 27.08 billion revenue by 2035.
The North America heart attack diagnostics market will dominate over 39.3% share by 2035, fueled by rising cardiac disease incidence, high healthcare spending, and advanced infrastructure.
Key players in the market include Abbott Laboratories, ACS Diagnostics, Company, Asahi Kasei Corporation, AstraZeneca PLC, Beckman Coulter, Inc., Hill-Rom Services, Inc, Koninklijke Philips N.V., General Electric Company, Toshiba Corporation, Schiller Americas, inc.
